Elevated levels of various interleukins (IL-1β, IL-2, IL-4, etc.)in the SCAP group further emphasized a more intense inflammatory response, potentially reflecting deeper or more extensive inflammation. The gene discussed is IL2; the disease is syringocystadenoma papilliferum.